APO Research
Talk to an analyst

APO RESEARCH · REPORT

Heparin Sodium

Heparin sodium is an anticoagulant (blood thinner) that prevents the formation of blood clots. Heparin is used to treat and prevent blood clots in the veins, arteries, or lung. It is also used before surgery to reduce the risk of blood clots.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Heparin sodium is an anticoagulant (blood thinner) that prevents the formation of blood clots. Heparin is used to treat and prevent blood clots in the veins, arteries, or lung. It is also used before surgery to reduce the risk of blood clots.

Selected research

Market Structure

Global Heparin Sodium Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

9 January 2026196 pages

Choose your research edition.

Industry ResearchHeparin Sodium Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Heparin Sodium Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Heparin Sodium Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Heparin Sodium Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Heparin Sodium Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

Heparin sodium is an anticoagulant (blood thinner) that prevents the formation of blood clots. Heparin is used to treat and prevent blood clots in the veins, arteries, or lung. It is also used before surgery to reduce the risk of blood clots.

Global Heparin Sodium key players include Shenzhen Hepalink, Bioibérica, Nanjing King-friend, Pfizer, Dongcheng Biochemicals, etc. Global top five manufacturers hold a share about 60%. China is the largest market, with a share about 60%, followed by Europe and North America, total with a share about 35 percent. In terms of application, the largest application is Treatment of Venous Thromboembolism, followed by Cardioversion of Atrial Fibrillation/Flutter, and Treatment of Venous Thromboembolism, etc.

This report provides an overview of the global Heparin Sodium market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Heparin Sodium and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Heparin Sodium sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Heparin Sodium market size, projected growth trends, production technologies, key applications, and end-use industries.

Heparin Sodium Segment by Company

Shenzhen Hepalink

Bioibérica

Nanjing King-friend

Pfizer

Dongcheng Biochemicals

Changzhou Qianhong Bio-pharma

Changshan Biochemical

Pharma Action

Baxter

Dongying Tiandong Pharmaceutical

Opocrin

Aspen Oss

Xinbai Pharmaceuticals

Yino Pharma Limited

Sichuan Deebio

Heparin Sodium Segment by Type

Oral Type

Injection Type

Heparin Sodium Segment by Application

Treatment of Venous Thromboembolism

Complications of Pregnancy

Cardioversion of Atrial Fibrillation/Flutter

Other

Heparin Sodium Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Heparin Sodium market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Heparin Sodium and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Heparin Sodium.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Heparin Sodium market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Heparin Sodium manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Heparin Sodium in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Heparin Sodium in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Heparin Sodium Industry Trends Table 2. Heparin Sodium Industry Drivers Table 3. Heparin Sodium Industry Opportunities and Challenges Table 4. Heparin Sodium Industry Restraints Table 5. Global Heparin Sodium Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Heparin Sodium Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Heparin Sodium Sales by Manufacturers (Kg) & (2021-2026) Table 8. Global Heparin Sodium Sales Market Share by Manufacturers Table 9. Global Heparin Sodium Average Sales Price (USD/Kg) of Manufacturers (2021-2026) Table 10. Global Heparin Sodium Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Heparin Sodium Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Heparin Sodium Manufacturers, Product Type & Application Table 13. Global Heparin Sodium Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Heparin Sodium by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Oral Type Table 17. Major Manufacturers of Injection Type Table 18. Global Heparin Sodium Sales by Type 2021 VS 2025 VS 2032 (Kg) Table 19. Global Heparin Sodium Sales by Type (2021-2026) & (Kg) Table 20. Global Heparin Sodium Sales by Type (2027-2032) & (Kg) Table 21. Global Heparin Sodium Sales Market Share by Type (2021-2026) Table 22. Global Heparin Sodium Sales Market Share by Type (2027-2032) Table 23. Global Heparin Sodium Revenue by Type 2021 VS 2025 VS 2032 (Kg) Table 24. Global Heparin Sodium Revenue by Type (2021-2026) & (Kg) Table 25. Global Heparin Sodium Revenue by Type (2027-2032) & (Kg) Table 26. Global Heparin Sodium Revenue Market Share by Type (2021-2026) Table 27. Global Heparin Sodium Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Treatment of Venous Thromboembolism Table 29. Major Manufacturers of Complications of Pregnancy Table 30. Major Manufacturers of Cardioversion of Atrial Fibrillation/Flutter Table 31. Major Manufacturers of Other Table 32. Global Heparin Sodium Sales by Application 2021 VS 2025 VS 2032 (Kg) Table 33. Global Heparin Sodium Sales by Application (2021-2026) & (Kg) Table 34. Global Heparin Sodium Sales by Application (2027-2032) & (Kg) Table 35. Global Heparin Sodium Sales Market Share by Application (2021-2026) Table 36. Global Heparin Sodium Sales Market Share by Application (2027-2032) Table 37. Global Heparin Sodium Revenue by Application 2021 VS 2025 VS 2032 (Kg) Table 38. Global Heparin Sodium Revenue by Application (2021-2026) & (Kg) Table 39. Global Heparin Sodium Revenue by Application (2027-2032) & (Kg) Table 40. Global Heparin Sodium Revenue Market Share by Application (2021-2026) Table 41. Global Heparin Sodium Revenue Market Share by Application (2027-2032) Table 42. Global Heparin Sodium Sales by Region: 2021 VS 2025 VS 2032 (Kg) Table 43. Global Heparin Sodium Sales by Region (2021-2026) & (Kg) Table 44. Global Heparin Sodium Sales Market Share by Region (2021-2026) Table 45. Global Heparin Sodium Sales Forecasted by Region (2027-2032) & (Kg) Table 46. Global Heparin Sodium Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Heparin Sodium Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Kg) Table 48. North America Heparin Sodium Sales by Country (2021-2026) & (Kg) Table 49. North America Heparin Sodium Sales by Country (2027-2032) & (Kg) Table 50. Europe Heparin Sodium Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Kg) Table 51. Europe Heparin Sodium Sales by Country (2021-2026) & (Kg) Table 52. Europe Heparin Sodium Sales by Country (2027-2032) & (Kg) Table 53. Asia Pacific Heparin Sodium Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Kg) Table 54. Asia Pacific Heparin Sodium Sales by Country (2021-2026) & (Kg) Table 55. Asia Pacific Heparin Sodium Sales by Country (2027-2032) & (Kg) Table 56. South America, Middle East and Africa Heparin Sodium Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Kg) Table 57. South America, Middle East and Africa Heparin Sodium Sales by Country (2021-2026) & (Kg) Table 58. South America, Middle East and Africa Heparin Sodium Sales by Country (2027-2032) & (Kg) Table 59. Global Heparin Sodium Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Heparin Sodium Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Heparin Sodium Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Heparin Sodium Revenue Market Share by Region (2021-2026) Table 63. Global Heparin Sodium Revenue Market Share by Region (2027-2032) Table 64. Shenzhen Hepalink Company Information Table 65. Shenzhen Hepalink Business Overview Table 66. Shenzhen Hepalink Heparin Sodium Sales (Kg), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Shenzhen Hepalink Heparin Sodium Product Portfolio Table 68. Shenzhen Hepalink Recent Development Table 69. Bioibérica Company Information Table 70. Bioibérica Business Overview Table 71. Bioibérica Heparin Sodium Sales (Kg), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Bioibérica Heparin Sodium Product Portfolio Table 73. Bioibérica Recent Development Table 74. Nanjing King-friend Company Information Table 75. Nanjing King-friend Business Overview Table 76. Nanjing King-friend Heparin Sodium Sales (Kg), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Nanjing King-friend Heparin Sodium Product Portfolio Table 78. Nanjing King-friend Recent Development Table 79. Pfizer Company Information Table 80. Pfizer Business Overview Table 81. Pfizer Heparin Sodium Sales (Kg), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Pfizer Heparin Sodium Product Portfolio Table 83. Pfizer Recent Development Table 84. Dongcheng Biochemicals Company Information Table 85. Dongcheng Biochemicals Business Overview Table 86. Dongcheng Biochemicals Heparin Sodium Sales (Kg), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Dongcheng Biochemicals Heparin Sodium Product Portfolio Table 88. Dongcheng Biochemicals Recent Development Table 89. Changzhou Qianhong Bio-pharma Company Information Table 90. Changzhou Qianhong Bio-pharma Business Overview Table 91. Changzhou Qianhong Bio-pharma Heparin Sodium Sales (Kg), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Changzhou Qianhong Bio-pharma Heparin Sodium Product Portfolio Table 93. Changzhou Qianhong Bio-pharma Recent Development Table 94. Changshan Biochemical Company Information Table 95. Changshan Biochemical Business Overview Table 96. Changshan Biochemical Heparin Sodium Sales (Kg), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Changshan Biochemical Heparin Sodium Product Portfolio Table 98. Changshan Biochemical Recent Development Table 99. Pharma Action Company Information Table 100. Pharma Action Business Overview Table 101. Pharma Action Heparin Sodium Sales (Kg), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Pharma Action Heparin Sodium Product Portfolio Table 103. Pharma Action Recent Development Table 104. Baxter Company Information Table 105. Baxter Business Overview Table 106. Baxter Heparin Sodium Sales (Kg), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Baxter Heparin Sodium Product Portfolio Table 108. Baxter Recent Development Table 109. Dongying Tiandong Pharmaceutical Company Information Table 110. Dongying Tiandong Pharmaceutical Business Overview Table 111. Dongying Tiandong Pharmaceutical Heparin Sodium Sales (Kg), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Dongying Tiandong Pharmaceutical Heparin Sodium Product Portfolio Table 113. Dongying Tiandong Pharmaceutical Recent Development Table 114. Opocrin Company Information Table 115. Opocrin Business Overview Table 116. Opocrin Heparin Sodium Sales (Kg), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Opocrin Heparin Sodium Product Portfolio Table 118. Opocrin Recent Development Table 119. Aspen Oss Company Information Table 120. Aspen Oss Business Overview Table 121. Aspen Oss Heparin Sodium Sales (Kg), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Aspen Oss Heparin Sodium Product Portfolio Table 123. Aspen Oss Recent Development Table 124. Xinbai Pharmaceuticals Company Information Table 125. Xinbai Pharmaceuticals Business Overview Table 126. Xinbai Pharmaceuticals Heparin Sodium Sales (Kg), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. Xinbai Pharmaceuticals Heparin Sodium Product Portfolio Table 128. Xinbai Pharmaceuticals Recent Development Table 129. Yino Pharma Limited Company Information Table 130. Yino Pharma Limited Business Overview Table 131. Yino Pharma Limited Heparin Sodium Sales (Kg), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 132. Yino Pharma Limited Heparin Sodium Product Portfolio Table 133. Yino Pharma Limited Recent Development Table 134. Sichuan Deebio Company Information Table 135. Sichuan Deebio Business Overview Table 136. Sichuan Deebio Heparin Sodium Sales (Kg), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 137. Sichuan Deebio Heparin Sodium Product Portfolio Table 138. Sichuan Deebio Recent Development Table 139. Key Raw Materials Table 140. Raw Materials Key Suppliers Table 141. Heparin Sodium Distributors List Table 142. Heparin Sodium Customers List Table 143. Research Programs/Design for This Report Table 144. Authors List of This Report Table 145. Secondary Sources Table 146. Primary Sources List of Figures Figure 1. Heparin Sodium Product Image Figure 2. Global Heparin Sodium Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Heparin Sodium Market Size (2021-2032) & (US$ Million) Figure 4. Global Heparin Sodium Sales (2021-2032) & (Kg) Figure 5. Global Heparin Sodium Average Price (USD/Kg) & (2021-2032) Figure 6. Global Top 5 and 10 Heparin Sodium Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Oral Type Image Figure 9. Injection Type Image Figure 10. Global Heparin Sodium Sales by Type (2021 VS 2025 VS 2032) & (Kg) Figure 11. Global Heparin Sodium Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Heparin Sodium Sales Market Share by Type (2021-2032) Figure 13. Global Heparin Sodium Revenue by Type (2021 VS 2025 VS 2032) & (Kg) Figure 14. Global Heparin Sodium Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Heparin Sodium Revenue Market Share by Type (2021-2032) Figure 16. Treatment of Venous Thromboembolism Image Figure 17. Complications of Pregnancy Image Figure 18. Cardioversion of Atrial Fibrillation/Flutter Image Figure 19. Other Image Figure 20. Global Heparin Sodium Sales by Application (2021 VS 2025 VS 2032) & (Kg) Figure 21. Global Heparin Sodium Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Heparin Sodium Sales Market Share by Application (2021-2032) Figure 23. Global Heparin Sodium Revenue by Application (2021 VS 2025 VS 2032) & (Kg) Figure 24. Global Heparin Sodium Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Heparin Sodium Revenue Market Share by Application (2021-2032) Figure 26. North America Heparin Sodium Sales and Growth Rate (2021-2032) & (Kg) Figure 27. North America Heparin Sodium Sales Market Share by Country (2021-2032) Figure 28. U.S. Heparin Sodium Sales and Growth Rate (2021-2032) & (Kg) Figure 29. Canada Heparin Sodium Sales and Growth Rate (2021-2032) & (Kg) Figure 30. Mexico Heparin Sodium Sales and Growth Rate (2021-2032) & (Kg) Figure 31. Europe Heparin Sodium Sales and Growth Rate (2021-2032) & (Kg) Figure 32. Europe Heparin Sodium Sales Market Share by Country (2021-2032) Figure 33. Germany Heparin Sodium Sales and Growth Rate (2021-2032) & (Kg) Figure 34. France Heparin Sodium Sales and Growth Rate (2021-2032) & (Kg) Figure 35. U.K. Heparin Sodium Sales and Growth Rate (2021-2032) & (Kg) Figure 36. Italy Heparin Sodium Sales and Growth Rate (2021-2032) & (Kg) Figure 37. Netherlands Heparin Sodium Sales and Growth Rate (2021-2032) & (Kg) Figure 38. Asia Pacific Heparin Sodium Sales and Growth Rate (2021-2032) & (Kg) Figure 39. Asia Pacific Heparin Sodium Sales Market Share by Country (2021-2032) Figure 40. China Heparin Sodium Sales and Growth Rate (2021-2032) & (Kg) Figure 41. Japan Heparin Sodium Sales and Growth Rate (2021-2032) & (Kg) Figure 42. South Korea Heparin Sodium Sales and Growth Rate (2021-2032) & (Kg) Figure 43. Southeast Asia Heparin Sodium Sales and Growth Rate (2021-2032) & (Kg) Figure 44. India Heparin Sodium Sales and Growth Rate (2021-2032) & (Kg) Figure 45. Australia Heparin Sodium Sales and Growth Rate (2021-2032) & (Kg) Figure 46. South America, Middle East and Africa Heparin Sodium Sales and Growth Rate (2021-2032) & (Kg) Figure 47. South America, Middle East and Africa Heparin Sodium Sales Market Share by Country (2021-2032) Figure 48. Brazil Heparin Sodium Sales and Growth Rate (2021-2032) & (Kg) Figure 49. South Africa Heparin Sodium Sales and Growth Rate (2021-2032) & (Kg) Figure 50. Saudi Arabia Heparin Sodium Sales and Growth Rate (2021-2032) & (Kg) Figure 51. Turkey Heparin Sodium Sales and Growth Rate (2021-2032) & (Kg) Figure 52. Argentina Heparin Sodium Sales and Growth Rate (2021-2032) & (Kg) Figure 53. UAE Heparin Sodium Sales and Growth Rate (2021-2032) & (Kg) Figure 54. Egypt Heparin Sodium Sales and Growth Rate (2021-2032) & (Kg) Figure 55. Chile Heparin Sodium Sales and Growth Rate (2021-2032) & (Kg) Figure 56. Global Heparin Sodium Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Heparin Sodium Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Heparin Sodium Revenue (2021-2032) & (US$ Million) Figure 59. North America Heparin Sodium Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Heparin Sodium Revenue (2021-2032) & (US$ Million) Figure 61. Europe Heparin Sodium Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Heparin Sodium Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Heparin Sodium Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Heparin Sodium Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Heparin Sodium Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Heparin Sodium Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Heparin Sodium Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Oral Type
  • Injection Type
Applications
  • Treatment of Venous Thromboembolism
  • Complications of Pregnancy
  • Cardioversion of Atrial Fibrillation/Flutter
  • Other
Companies covered
  • Shenzhen Hepalink
  • Bioibérica
  • Nanjing King-friend
  • Pfizer
  • Dongcheng Biochemicals
  • Changzhou Qianhong Bio-pharma
  • Changshan Biochemical
  • Pharma Action
  • Baxter
  • Dongying Tiandong Pharmaceutical
  • Opocrin
  • Aspen Oss
  • Xinbai Pharmaceuticals
  • Yino Pharma Limited
  • Sichuan Deebio

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Heparin Sodium Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Heparin Sodium Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Heparin Sodium Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Heparin Sodium Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Heparin Sodium Market Dynamics
  1. 2.1 Heparin Sodium Industry Trends
  2. 2.2 Heparin Sodium Industry Drivers
  3. 2.3 Heparin Sodium Industry Opportunities and Challenges
  4. 2.4 Heparin Sodium Industry Restraints
3 Heparin Sodium Market by Manufacturers
  1. 3.1 Global Heparin Sodium Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Heparin Sodium Sales by Manufacturers (2021-2026)
  3. 3.3 Global Heparin Sodium Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Heparin Sodium Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Heparin Sodium Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Heparin Sodium Manufacturers, Product Type & Application
  7. 3.7 Global Heparin Sodium Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Heparin Sodium Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Heparin Sodium Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Heparin Sodium Tier 1, Tier 2, and Tier 3
4 Heparin Sodium Market by Type
  1. 4.1 Heparin Sodium Type Introduction
  2. 4.1.1 Oral Type
  3. 4.1.2 Injection Type
  4. 4.2 Global Heparin Sodium Sales by Type
  5. 4.2.1 Global Heparin Sodium Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Heparin Sodium Sales by Type (2021-2032)
  7. 4.2.3 Global Heparin Sodium Sales Market Share by Type (2021-2032)
  8. 4.3 Global Heparin Sodium Revenue by Type
  9. 4.3.1 Global Heparin Sodium Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Heparin Sodium Revenue by Type (2021-2032)
  11. 4.3.3 Global Heparin Sodium Revenue Market Share by Type (2021-2032)
5 Heparin Sodium Market by Application
  1. 5.1 Heparin Sodium Application Introduction
  2. 5.1.1 Treatment of Venous Thromboembolism
  3. 5.1.2 Complications of Pregnancy
  4. 5.1.3 Cardioversion of Atrial Fibrillation/Flutter
  5. 5.1.4 Other
  6. 5.2 Global Heparin Sodium Sales by Application
  7. 5.2.1 Global Heparin Sodium Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Heparin Sodium Sales by Application (2021-2032)
  9. 5.2.3 Global Heparin Sodium Sales Market Share by Application (2021-2032)
  10. 5.3 Global Heparin Sodium Revenue by Application
  11. 5.3.1 Global Heparin Sodium Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Heparin Sodium Revenue by Application (2021-2032)
  13. 5.3.3 Global Heparin Sodium Revenue Market Share by Application (2021-2032)
6 Global Heparin Sodium Sales by Region
  1. 6.1 Global Heparin Sodium Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Heparin Sodium Sales by Region (2021-2032)
  3. 6.2.1 Global Heparin Sodium Sales by Region (2021-2026)
  4. 6.2.2 Global Heparin Sodium Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Heparin Sodium Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Heparin Sodium Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Heparin Sodium Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Heparin Sodium Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Heparin Sodium Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Heparin Sodium Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Heparin Sodium Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Heparin Sodium Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Heparin Sodium Revenue by Region
  1. 7.1 Global Heparin Sodium Revenue by Region
  2. 7.1.1 Global Heparin Sodium Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Heparin Sodium Revenue by Region (2021-2026)
  4. 7.1.3 Global Heparin Sodium Revenue by Region (2027-2032)
  5. 7.1.4 Global Heparin Sodium Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Heparin Sodium Revenue (2021-2032)
  8. 7.2.2 North America Heparin Sodium Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Heparin Sodium Revenue (2021-2032)
  11. 7.3.2 Europe Heparin Sodium Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Heparin Sodium Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Heparin Sodium Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Heparin Sodium Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Heparin Sodium Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Shenzhen Hepalink
  2. 8.1.1 Shenzhen Hepalink Company Information
  3. 8.1.2 Shenzhen Hepalink Business Overview
  4. 8.1.3 Shenzhen Hepalink Heparin Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Shenzhen Hepalink Heparin Sodium Product Portfolio
  6. 8.1.5 Shenzhen Hepalink Recent Developments
  7. 8.2 Bioibérica
  8. 8.2.1 Bioibérica Company Information
  9. 8.2.2 Bioibérica Business Overview
  10. 8.2.3 Bioibérica Heparin Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Bioibérica Heparin Sodium Product Portfolio
  12. 8.2.5 Bioibérica Recent Developments
  13. 8.3 Nanjing King-friend
  14. 8.3.1 Nanjing King-friend Company Information
  15. 8.3.2 Nanjing King-friend Business Overview
  16. 8.3.3 Nanjing King-friend Heparin Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Nanjing King-friend Heparin Sodium Product Portfolio
  18. 8.3.5 Nanjing King-friend Recent Developments
  19. 8.4 Pfizer
  20. 8.4.1 Pfizer Company Information
  21. 8.4.2 Pfizer Business Overview
  22. 8.4.3 Pfizer Heparin Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Pfizer Heparin Sodium Product Portfolio
  24. 8.4.5 Pfizer Recent Developments
  25. 8.5 Dongcheng Biochemicals
  26. 8.5.1 Dongcheng Biochemicals Company Information
  27. 8.5.2 Dongcheng Biochemicals Business Overview
  28. 8.5.3 Dongcheng Biochemicals Heparin Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Dongcheng Biochemicals Heparin Sodium Product Portfolio
  30. 8.5.5 Dongcheng Biochemicals Recent Developments
  31. 8.6 Changzhou Qianhong Bio-pharma
  32. 8.6.1 Changzhou Qianhong Bio-pharma Company Information
  33. 8.6.2 Changzhou Qianhong Bio-pharma Business Overview
  34. 8.6.3 Changzhou Qianhong Bio-pharma Heparin Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Changzhou Qianhong Bio-pharma Heparin Sodium Product Portfolio
  36. 8.6.5 Changzhou Qianhong Bio-pharma Recent Developments
  37. 8.7 Changshan Biochemical
  38. 8.7.1 Changshan Biochemical Company Information
  39. 8.7.2 Changshan Biochemical Business Overview
  40. 8.7.3 Changshan Biochemical Heparin Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Changshan Biochemical Heparin Sodium Product Portfolio
  42. 8.7.5 Changshan Biochemical Recent Developments
  43. 8.8 Pharma Action
  44. 8.8.1 Pharma Action Company Information
  45. 8.8.2 Pharma Action Business Overview
  46. 8.8.3 Pharma Action Heparin Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Pharma Action Heparin Sodium Product Portfolio
  48. 8.8.5 Pharma Action Recent Developments
  49. 8.9 Baxter
  50. 8.9.1 Baxter Company Information
  51. 8.9.2 Baxter Business Overview
  52. 8.9.3 Baxter Heparin Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Baxter Heparin Sodium Product Portfolio
  54. 8.9.5 Baxter Recent Developments
  55. 8.10 Dongying Tiandong Pharmaceutical
  56. 8.10.1 Dongying Tiandong Pharmaceutical Company Information
  57. 8.10.2 Dongying Tiandong Pharmaceutical Business Overview
  58. 8.10.3 Dongying Tiandong Pharmaceutical Heparin Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Dongying Tiandong Pharmaceutical Heparin Sodium Product Portfolio
  60. 8.10.5 Dongying Tiandong Pharmaceutical Recent Developments
  61. 8.11 Opocrin
  62. 8.11.1 Opocrin Company Information
  63. 8.11.2 Opocrin Business Overview
  64. 8.11.3 Opocrin Heparin Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Opocrin Heparin Sodium Product Portfolio
  66. 8.11.5 Opocrin Recent Developments
  67. 8.12 Aspen Oss
  68. 8.12.1 Aspen Oss Company Information
  69. 8.12.2 Aspen Oss Business Overview
  70. 8.12.3 Aspen Oss Heparin Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Aspen Oss Heparin Sodium Product Portfolio
  72. 8.12.5 Aspen Oss Recent Developments
  73. 8.13 Xinbai Pharmaceuticals
  74. 8.13.1 Xinbai Pharmaceuticals Company Information
  75. 8.13.2 Xinbai Pharmaceuticals Business Overview
  76. 8.13.3 Xinbai Pharmaceuticals Heparin Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Xinbai Pharmaceuticals Heparin Sodium Product Portfolio
  78. 8.13.5 Xinbai Pharmaceuticals Recent Developments
  79. 8.14 Yino Pharma Limited
  80. 8.14.1 Yino Pharma Limited Company Information
  81. 8.14.2 Yino Pharma Limited Business Overview
  82. 8.14.3 Yino Pharma Limited Heparin Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Yino Pharma Limited Heparin Sodium Product Portfolio
  84. 8.14.5 Yino Pharma Limited Recent Developments
  85. 8.15 Sichuan Deebio
  86. 8.15.1 Sichuan Deebio Company Information
  87. 8.15.2 Sichuan Deebio Business Overview
  88. 8.15.3 Sichuan Deebio Heparin Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Sichuan Deebio Heparin Sodium Product Portfolio
  90. 8.15.5 Sichuan Deebio Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Heparin Sodium Value Chain Analysis
  2. 9.1.1 Heparin Sodium Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Heparin Sodium Production Mode & Process
  6. 9.2 Heparin Sodium Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Heparin Sodium Distributors
  9. 9.2.3 Heparin Sodium Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst